Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells
- PMID: 17343295
- DOI: 10.1002/eji.200636690
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells
Abstract
Following CD80/86 (B7) and TLR9 ligation, small subsets of splenic dendritic cells expressing CD19 (CD19(+) DC) acquire potent T cell regulatory functions due to induced expression of the intracellular enzyme indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan. In CD19(+) DC, IFN type I (IFN-alpha) is the obligate inducer of IDO. We now report that IFN-alpha production needed to stimulate high-level expression of IDO following B7 ligation is itself dependent on basal levels of IDO activity. Genetic and pharmacologic ablation of IDO completely abrogated IFN-alpha production by CD19(+) DC after B7 ligation. In contrast, IDO ablation did not block IFN-alpha production by CD19(+) DC after TLR9 ligation. IDO-mediated control of IFN-alpha production depended on tryptophan depletion as adding excess tryptophan also blocked IFN-alpha expression after B7 ligation. Consistent with this, DC from mice deficient in general control of non-derepressible-2 (GCN2)-kinase, a component of the cellular stress response to amino acid withdrawal, did not produce IFN-alpha following B7 ligation, but produced IFN-alpha after TLR9 ligation. Thus, B7 and TLR9 ligands stimulate IFN-alpha expression in CD19(+) DC via distinct signaling pathways. In the case of B7 ligation, IDO activates cell-autonomous signals essential for IFN-alpha production, most likely by activating the GCN2-kinase-dependent stress response.
Similar articles
-
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.Int Immunol. 2005 Jul;17(7):909-19. doi: 10.1093/intimm/dxh271. Epub 2005 Jun 20. Int Immunol. 2005. PMID: 15967784
-
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.Int Immunol. 2004 Oct;16(10):1391-401. doi: 10.1093/intimm/dxh140. Epub 2004 Sep 6. Int Immunol. 2004. PMID: 15351783
-
Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.J Immunol. 2009 Nov 1;183(9):5608-14. doi: 10.4049/jimmunol.0804116. J Immunol. 2009. PMID: 19843945
-
On watching the watchers: IDO and type I/II IFN.Eur J Immunol. 2007 Apr;37(4):876-9. doi: 10.1002/eji.200737184. Eur J Immunol. 2007. PMID: 17393386 Review.
-
Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Eur J Immunol. 2012 Aug;42(8):1932-7. doi: 10.1002/eji.201242572. Eur J Immunol. 2012. PMID: 22865044 Review.
Cited by
-
Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases.Mediators Inflamm. 2013;2013:391984. doi: 10.1155/2013/391984. Epub 2013 Feb 18. Mediators Inflamm. 2013. PMID: 23476103 Free PMC article. Review.
-
IDO-expressing regulatory dendritic cells in cancer and chronic infection.J Mol Med (Berl). 2008 Feb;86(2):145-60. doi: 10.1007/s00109-007-0262-6. Epub 2007 Sep 18. J Mol Med (Berl). 2008. PMID: 17876564 Review.
-
IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.J Immunol. 2009 Aug 15;183(4):2475-83. doi: 10.4049/jimmunol.0900986. Epub 2009 Jul 27. J Immunol. 2009. PMID: 19635913 Free PMC article.
-
Assessment of interferon gamma and indoleamine 2,3-dioxygenase 1 analysis during respiratory syncytial virus infection in infants in Italy: an observational case-control study.BMJ Open. 2022 Feb 28;12(2):e053323. doi: 10.1136/bmjopen-2021-053323. BMJ Open. 2022. PMID: 35228282 Free PMC article.
-
Prevention and treatment of cancers by immune modulating nutrients.Mol Nutr Food Res. 2016 Jun;60(6):1275-94. doi: 10.1002/mnfr.201500884. Epub 2016 Mar 9. Mol Nutr Food Res. 2016. PMID: 26833775 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials